🇺🇸 FDA
Patent

US 12209119

Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids

granted A61KA61K2039/505

Quick answer

US patent 12209119 (Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids) held by The Regents of the University of California expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505